Artal Group’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.77M | Hold |
|
|||||
|
2024
Q1 | $4.98M | Hold |
|
|||||
|
2023
Q4 | $4.49M | Hold |
|
|||||
|
2023
Q3 | $14.2M | Hold |
|
|||||
|
2023
Q2 | $22.4M | Buy |
|
|||||
|
2023
Q1 | $22M | Hold |
|
|||||
|
2022
Q4 | $28.6M | Hold |
|
|||||
|
2022
Q3 | $44M | Buy |
|
|||||
|
2022
Q2 | $9.06M | Hold |
|
|||||
|
2022
Q1 | $15.7M | Hold |
|
|||||
|
2021
Q4 | $30.1M | Hold |
|
|||||
|
2021
Q3 | $58.2M | Hold |
|
|||||
|
2021
Q2 | $45.9M | Hold |
|
|||||
|
2021
Q1 | $54.4M | Hold |
|
|||||
|
2020
Q4 | $89.3M | Hold |
|
|||||
|
2020
Q3 | $63.9M | Buy |
|